Evidence map›Paper›PMID 30884810›Full record

ArticleInternational journal of molecular sciences2019

Mateus Camargo Barros-Filho, Larissa Barreto Menezes de Lima, Mariana Bisarro Dos Reis, Julia Bette Homem de Mello, Caroline Moraes Beltrami, Clóvis Antonio Lopes Pinto, Luiz Paulo Kowalski, Silvia Regina Rogatto

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Signal integrator function of CXXC5 in Cancer.Cell communication and signaling : CCS · 2025
    Review
  4. The role of epigenetic methylations in thyroid Cancer.World journal of surgical oncology · 2024
    Review
  5. Article
  6. The Antitumour Effect ofEvidence-based complementary and alternative medicine : eCAM · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Cell and Molecular Biology of Thyroid Disorders.International journal of molecular sciences · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Mateus Camargo Barros-FilhoInternational Research Center-CIPE-A.C.Camargo Cancer Center, São Paulo 01508-010, Brazil. mfilho@accamargo.org.br.
Larissa Barreto Menezes de LimaInternational Research Center-CIPE-A.C.Camargo Cancer Center, São Paulo 01508-010, Brazil. larissamenezes@outlook.pt.
Mariana Bisarro Dos ReisInternational Research Center-CIPE-A.C.Camargo Cancer Center, São Paulo 01508-010, Brazil. marianabisarro@yahoo.com.br.
Julia Bette Homem de MelloInternational Research Center-CIPE-A.C.Camargo Cancer Center, São Paulo 01508-010, Brazil. juliahmello@gmail.com.
Caroline Moraes BeltramiInternational Research Center-CIPE-A.C.Camargo Cancer Center, São Paulo 01508-010, Brazil. cahbeltrami@gmail.com.
Clóvis Antonio Lopes PintoDepartment of Pathology, A.C.Camargo Cancer Center, São Paulo 01509-900, Brazil. calopes@accamargo.org.br.
Luiz Paulo KowalskiDepartment of Head and Neck Surgery and Otorhinolaryngology, A.C. Camargo Cancer Center, São Paulo 01509-900, Brazil. lp_kowalski@uol.com.br.
Silvia Regina RogattoDepartment of Clinical Genetics, Vejle Hospital, Institute of Regional Health Research, University of Southern Denmark, 7100 Vejle, Denmark. silvia.regina.rogatto@rsyd.dk.
AC Camargo Hospital · BRUniversity of Southern Denmark · DK

Funding

Fundação de Amparo à Pesquisa do Estado de São Paulo 2015/20748-5; 2015/17707-5
6 · The paper itself

Abstract

Despite the low mortality rates, well-differentiated thyroid carcinomas (WDTC) frequently relapse.

Indexed as

AdultAgedBiomarkers, TumorCell DifferentiationDNA MethylationFemaleHumansMaleMiddle AgedMutationNeoplasm Recurrence, LocalPhosphofructokinase-2PrognosisPromoter Regions, GeneticProto-Oncogene Proteins B-rafTelomeraseBiomarkers, TumorBRAF protein, humanPFKFB2 protein, humanPhosphofructokinase-2Proto-Oncogene Proteins B-rafTelomeraseTERT protein, humanBRAF mutationDNA methylationPFKFB2prognosisTERT promoter mutationwell-differentiated thyroid carcinoma

Identifiers

PMID30884810
PMCPMC6471408
OpenAlexW2921700880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.